Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Amyloid-beta impairs TOM1-mediated IL-1R1 signaling.

Alessandra Cadete Martini | Angela Gomez-Arboledas | Stefania Forner | Carlos J Rodriguez-Ortiz | Amanda McQuade | Emma Danhash | Jimmy Phan | Dominic Javonillo | Jordan-Vu Ha | Melanie Tram | Laura Trujillo-Estrada | Celia da Cunha | Rahasson R Ager | Jose C Davila | Masashi Kitazawa | Mathew Blurton-Jones | Antonia Gutierrez | David Baglietto-Vargas | Rodrigo Medeiros | Frank M LaFerla
Proceedings of the National Academy of Sciences of the United States of America | 2019

Defects in interleukin-1β (IL-1β)-mediated cellular responses contribute to Alzheimer's disease (AD). To decipher the mechanism associated with its pathogenesis, we investigated the molecular events associated with the termination of IL-1β inflammatory responses by focusing on the role played by the target of Myb1 (TOM1), a negative regulator of the interleukin-1β receptor-1 (IL-1R1). We first show that TOM1 steady-state levels are reduced in human AD hippocampi and in the brain of an AD mouse model versus respective controls. Experimentally reducing TOM1 affected microglia activity, substantially increased amyloid-beta levels, and impaired cognition, whereas enhancing its levels was therapeutic. These data show that reparation of the TOM1-signaling pathway represents a therapeutic target for brain inflammatory disorders such as AD. A better understanding of the age-related changes in the immune system will allow us to craft therapies to limit detrimental aspects of inflammation, with the broader purpose of sharply reducing the number of people afflicted by AD.

Pubmed ID: 31570577

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NIA NIH HHS, United States
    Id: P01 AG000538
  • Agency: NIA NIH HHS, United States
    Id: P50 AG016573
  • Agency: NINDS NIH HHS, United States
    Id: T32 NS082174

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


PRISM (tool)

RRID:SCR_005375

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on May 5,2022.Tool that predicts interactions between transcription factors and their regulated genes from binding motifs. Understanding vertebrate development requires unraveling the cis-regulatory architecture of gene regulation. PRISM provides accurate genome-wide computational predictions of transcription factor binding sites for the human and mouse genomes, and integrates the predictions with GREAT to provide functional biological context. Together, accurate computational binding site prediction and GREAT produce for each transcription factor: 1. putative binding sites, 2. putative target genes, 3. putative biological roles of the transcription factor, and 4. putative cis-regulatory elements through which the factor regulates each target in each functional role.

View all literature mentions

Imaris (tool)

RRID:SCR_007370

Imaris provides range of capabilities for working with three dimensional images. Uses flexible editing and processing functions, such as interactive surface rendering and object slicing capabilities. And output to standard TIFF, Quicktime and AVI formats. Imaris accepts virtually all image formats that are used in confocal microscopy and many of those used in wide-field image acquisition.

View all literature mentions

B6;129-Tg(APPSwe,tauP301L)1Lfa Psen1tm1Mpm/Mmjax (tool)

RRID:MMRRC_034830-JAX

Mus musculus with name B6;129-Tg(APPSwe,tauP301L)1Lfa Psen1tm1Mpm/Mmjax from MMRRC.

View all literature mentions